HCA
Harbor Capital Advisors Portfolio holdings
AUM
$2.38B
1-Year Return
20%
This Quarter Return
-2.65%
1 Year Return
+20%
3 Year Return
+97.89%
5 Year Return
–
10 Year Return
–
AUM
$468M
AUM Growth
-$32.3M
(-6.5%)
Cap. Flow
-$11.6M
Cap. Flow
% of AUM
-2.48%
Top 10 Holdings %
Top 10 Hldgs %
23.97%
Holding
674
New
13
Increased
155
Reduced
183
Closed
230
Top Buys
| 1 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
$3.45M |
| 2 |
Affirm
AFRM
|
$989K |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
$689K |
| 4 |
IAUF
iShares Gold Strategy ETF
IAUF
|
$500K |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$408K |
Top Sells
| 1 |
Icon
ICLR
|
$987K |
| 2 |
T-Mobile US
TMUS
|
$874K |
| 3 |
Duolingo
DUOL
|
$666K |
| 4 |
UnitedHealth
UNH
|
$580K |
| 5 |
Masimo
MASI
|
$570K |
Sector Composition
| 1 | Technology | 27.52% |
| 2 | Healthcare | 15.98% |
| 3 | Financials | 10.93% |
| 4 | Communication Services | 8.21% |
| 5 | Consumer Discretionary | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Constellation Brands
STZ
$26.2B
| $588K | 0.13% |
2,341
| – | – |
|
202
Helen of Troy
HELE
$587M
| $584K | 0.12% |
5,008
+62
| +1% | +$7.23K |
|
203
Steelcase
SCS
$1.97B
| $578K | 0.12% |
51,703
-4,456
| -8% | -$49.8K |
|
|
RPT
204
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $574K | 0.12% |
54,343
+2,309
| +4% | +$24.4K |
|
205
Gogo Inc
GOGO
$1.43B
| $567K | 0.12% |
47,488
+11,173
| +31% | +$133K |
|
206
Live Oak Bancshares
LOB
$1.75B
| $562K | 0.12% |
19,424
-5,084
| -21% | -$147K |
|
|
ARGO
207
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $562K | 0.12% |
18,836
-1,128
| -6% | -$33.7K |
|
208
Invesco S&P SmallCap Industrials ETF
PSCI
$137M
| $553K | 0.12% |
5,559
+296
| +6% | +$29.4K |
|
209
Veritex Holdings
VBTX
$1.87B
| $553K | 0.12% |
30,784
-6,616
| -18% | -$119K |
|
210
Varonis Systems
VRNS
$6.28B
| $550K | 0.12% |
18,010
-1,901
| -10% | -$58.1K |
|
211
Toast
TOST
$24B
| $549K | 0.12% |
29,315
-9,756
| -25% | -$183K |
|
212
GE HealthCare
GEHC
$34.6B
| $541K | 0.12% |
7,954
+293
| +4% | +$19.9K |
|
213
Arrowhead Research
ARWR
$4.02B
| $541K | 0.12% |
20,135
+2,880
| +17% | +$77.4K |
|
214
SBA Communications
SBAC
$21.2B
| $539K | 0.12% |
2,692
+78
| +3% | +$15.6K |
|
215
Calix
CALX
$3.96B
| $528K | 0.11% |
11,529
+394
| +4% | +$18.1K |
|
216
Marvell Technology
MRVL
$54.6B
| $528K | 0.11% |
9,759
| – | – |
|
217
PG&E
PCG
$33.2B
| $528K | 0.11% |
32,721
| – | – |
|
218
Intellia Therapeutics
NTLA
$1.29B
| $525K | 0.11% |
16,604
+2,610
| +19% | +$82.5K |
|
219
Twist Bioscience
TWST
$1.55B
| $525K | 0.11% |
25,897
+1,062
| +4% | +$21.5K |
|
220
Replimune Group
REPL
$494M
| $521K | 0.11% |
30,467
+4,699
| +18% | +$80.4K |
|
221
Autodesk
ADSK
$69.5B
| $518K | 0.11% |
2,502
| – | – |
|
222
Expedia Group
EXPE
$26.6B
| $517K | 0.11% |
5,015
| – | – |
|
223
Bristow Group
VTOL
$1.09B
| $516K | 0.11% |
18,301
+4,015
| +28% | +$113K |
|
224
Sprout Social
SPT
$891M
| $515K | 0.11% |
10,334
+452
| +5% | +$22.5K |
|
225
Alnylam Pharmaceuticals
ALNY
$59.2B
| $511K | 0.11% |
2,887
+163
| +6% | +$28.9K |
|